Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.
ClinicalTrials.gov study NCT05753826. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05456685. IPD Sharing: NO. Countries: 6. Publications: 0.
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
ClinicalTrials.gov study NCT04177082. IPD Sharing: NO. Countries: 1. Publications: 0.
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04938583. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma
ClinicalTrials.gov study NCT06151743. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen
ClinicalTrials.gov study NCT04549025. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy
ClinicalTrials.gov study NCT01856101. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer
ClinicalTrials.gov study NCT03841136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01570582. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma
ClinicalTrials.gov study NCT00429559. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Che
ClinicalTrials.gov study NCT03830918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
ClinicalTrials.gov study NCT03130829. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01883297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05467670. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05198804. IPD Sharing: NO. Countries: 2. Publications: 0.
Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT02855697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04921527. IPD Sharing: NO. Countries: 1. Publications: 0.
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05979818. IPD Sharing: NO. Countries: 1. Publications: 0.
Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT04068974. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT03391479. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.